Non-interventional Study With NOVOCART® Basic in Patients Treated for Cartilage Defects in the Knee With MAC

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

July 24, 2019

Study Completion Date

July 24, 2019

Conditions
Cartilage Diseases
Interventions
DEVICE

MAC with NOVOCART Basic

"NOVOCART® Basic is a biphasic, collagen-based matrix to support the biological reconstruction of localized and full-thickness cartilage damages after treatment with bone marrow stimulation techniques (microfracture). The procedure is called matrix associated chondrogenesis (MAC). It is a single-step procedure.~NOVOCART® Basic is tailored to fit the prepared defect size and is inserted in the defect area after microfracture. The NOVOCART® Basic device component is fully resorbed over a period of a few months as new reparative cartilage tissue is generated and integrated with the surrounding host tissue."

Trial Locations (3)

3012

Cartilage Care, Bern

4132

Praxisklinik Rennbahn AG, Muttenz

68165

Theresienkrankenhaus und St. Hedwig-Klinik GmbH, Mannheim

All Listed Sponsors
collaborator

Aesculap AG

INDUSTRY

collaborator

Winicker Norimed GmbH

INDUSTRY

lead

Tetec AG

INDUSTRY

NCT03808623 - Non-interventional Study With NOVOCART® Basic in Patients Treated for Cartilage Defects in the Knee With MAC | Biotech Hunter | Biotech Hunter